lenvatinib and Wet-Macular-Degeneration

lenvatinib has been researched along with Wet-Macular-Degeneration* in 1 studies

Other Studies

1 other study(ies) available for lenvatinib and Wet-Macular-Degeneration

Article	Year
Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD. Experimental eye research, 2018, Volume: 168 Topics: Administration, Oral; Analysis of Variance; Angiogenesis Inhibitors; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Choroidal Neovascularization; Disease Models, Animal; Humans; Mice; Phenylurea Compounds; Protein Kinase Inhibitors; Quinolines; Vascular Endothelial Growth Factor A; Wet Macular Degeneration	2018

Article

Year

Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.

Experimental eye research, 2018, Volume: 168

Topics: Administration, Oral; Analysis of Variance; Angiogenesis Inhibitors; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Choroidal Neovascularization; Disease Models, Animal; Humans; Mice; Phenylurea Compounds; Protein Kinase Inhibitors; Quinolines; Vascular Endothelial Growth Factor A; Wet Macular Degeneration

2018